Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ACADIA Pharmaceuticals Inc ACAD

Healthcare Biotechnology
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders... see more

Recent & Breaking News (NDAQ:ACAD)

ACADIA Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 7, 2013

Business Wire April 30, 2013

ACADIA Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference on April 30, 2013

Business Wire April 25, 2013

InvestorsGuru.com 45 Filtered Mid-Day Market Movers Recap

Investors Guru April 14, 2013

Free Research Reports on ACAD, BBBY, SSH and YUM Issued by the Paragon Report

Marketwired April 12, 2013

GOFF Corporation Shares Halt The Slide Looking For Follow Through- Top Five Small Cap Stocks Ahead Of The Bell: Lyon Williams, Acadia Pharmaceutical, Fannie Mae, AMR Corporation

PR Newswire April 12, 2013

Retailers Push Stocks Higher and Pfizer Inc. hits a new 52-Week High

PR Newswire April 12, 2013

BioStock Break Out Watch List Initiated with ACAD, AMRN and CELG

Accesswire April 11, 2013

ACADIA Pharmaceuticals Announces Expedited Path to NDA Filing for Pimavanserin Following Meeting with FDA

Business Wire April 11, 2013

Over $400 Million Raised by U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings in 2012, Reports Brinson Patrick

PR Newswire April 8, 2013

Pre-Market Analysis on Dendreon, ACADIA Pharma, Medivation, and Cell Therapeutics

PR Newswire April 5, 2013

Acadia Pharmaceuticals and ON Semiconductor Trend Analysis Reports: (NASDAQ: ACAD), (NASDAQ: ONNN)

Accesswire March 25, 2013

InvestorsGuru.com Filtered Mid-Day Market Movers Recap

Investors Guru March 24, 2013

Apple Shares Bounce on Rumored iPhone 5S

PR Newswire March 22, 2013

Free Research Reports on ACAD, ANAC, AFFY and DNN Issued by the Bedford Report

Marketwired March 22, 2013

ACADIA Pharmaceuticals Inc. & SUPERVALU Inc. Announcements: (NASDAQ: ACAD), (NYSE: SVU)

Accesswire March 22, 2013

ACADIA Announces Presentation of Data from Its Pivotal Phase III Parkinson's Disease Psychosis Study with Pimavanserin at the American Academy of Neurology Annual Meeting

Business Wire March 20, 2013

FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing

Marketwired March 15, 2013

ACADIA Pharmaceuticals to Present at the 25th Annual ROTH Conference on March 19, 2013

Business Wire March 13, 2013

ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012

Business Wire March 12, 2013

Today's Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics

PR Newswire March 6, 2013